Navigation Links
Acumed Signs Agreement with Vivorte to Distribute its Orthobiologics Portfolio
Date:3/13/2020

Acumed LLC today announced that it has entered into an agreement with Vivorte Inc. to be the exclusive distributor of the Louisville-based company’s orthobiologics portfolio. Under the terms of the agreement, Acumed will employ its sales, marketing, and medical education expertise to distribute Vivorte’s calcium phosphate-based bone allograft (Trabexus) and calcium phosphate-based biocement (Fortera). Vivorte will continue to utilize its product development and manufacturing capabilities to support the distribution.

“As a leader in the orthopaedic sector, Acumed is committed to providing the most comprehensive clinical solutions to our surgeons and this partnership with Vivorte allows us to deliver a best-in-class portfolio of orthobiologic technologies,” said Jagi Gill, Vice President/General Manager of AcuVentures at Acumed. “The Trabexus and Fortera products provide our surgeons the distinguishing features of ease of use, strength, and remodeling that are requisite in premier bone allografts and bone void fillers.”

The Trabexus product line is a self-setting calcium phosphate matrix with engineered allograft bone particles for optimized compressive strength and resorptive characteristics. Fortera is an osteoconductive biocement that combines industry leading compressive strength with superior flow characteristics. In the US alone, the orthobiologics market is estimated to be in excess of $550 million, of which the synthetic allograft market occupies a significant and growing segment.

Mark Wagner, CEO of Vivorte, commented, “We have been pleased with the strong clinical support and adoption of our products in the market. Partnering with Acumed, we will reach more surgeons to the benefit of more patients, thereby extending the commercial footprint for our orthobiologic technologies. This works because the two companies share a common vision of delivering innovative solutions in a quality-first culture.”

About Acumed
Acumed is a global leader in developing innovative orthopaedic and medical solutions to improve patient care. Acumed has more than three decades of experience in the orthopaedic industry, with the mission of aiding the afflicted through the ingenuity of our minds, the labor of our hands, and the compassion of our hearts. Founded in 1988, Acumed is headquartered in Hillsboro, Oregon, with offices and a distribution network around the world. For more information, visit http://www.acumed.net.

Read the full story at https://www.prweb.com/releases/acumed_signs_agreement_with_vivorte_to_distribute_its_orthobiologics_portfolio/prweb16973753.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. Encouraging signs for bee biodiversity
2. Light and nanoprobes detect early signs of infection
3. Fluke Biomedical launches portable, feature-rich ProSim 3 and 2 Vital Signs Simulators
4. Leopoldina signs cooperation agreement with the Academy of Science of South Africa
5. BioClaim, Inc. Signs Biometric Software Contract with Amerigroup Florida
6. Switzerland signs the ELIXIR consortium agreement and contributes €35 million
7. Research reveals new understanding, warning signs, and potential treatments for multiple sclerosis
8. A*STAR signs agreement with Nestlé to strengthen food & nutrition R&D in Singapore
9. Quick test finds signs of diarrheal disease
10. Small non-coding RNAs could be warning signs of cancer
11. ARUP Labs signs agreement with UH Case Medical Center to distribute novel DEEPGEN HIV test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2020)... ALPHARETTA, Ga. (PRWEB) , ... ... ... provider of Human Capital IntegritySM technology-based services specializing in background and medical ... with their COVID-19 return-to-work planning and keeping their workforce safe. The new ...
(Date:5/21/2020)... ... May 20, 2020 , ... Law Enforcement has always been a highly stressful ... The positions of these men and women put them constantly in harm’s way both ... precisely. Officers have always had to face very high daily stress. Now, COVID-19 introduces ...
(Date:5/14/2020)... ... May 12, 2020 , ... ... accurately and easily project contracted liabilities with payers, providers and pharmacies – ... discounts/rebates to Commercial and Government entities, Copay and Patient Assistance Program liabilities ...
Breaking Biology News(10 mins):
(Date:5/21/2020)... ... May 21, 2020 , ... Threats to intellectual property, ... , Contrary to conventional wisdom that says the coronavirus pandemic will generally benefit ... emerge from the pandemic commercially weaker, dealing with delays in new product launches ...
(Date:5/21/2020)... (PRWEB) , ... May 20, 2020 , ... ... addition of Simon Prakash, who will serve as the company’s executive vice president ... a time when Exo is disrupting the medical imaging space, bringing more than ...
(Date:5/15/2020)... ... ... This new service offers clients a way to speak with Subject Matter ... need arises. Lachman’s OnCall SMEs have extensive knowledge of a wide range of scientific, ... SMEs are available normal business hours Monday through Friday from 9:00 am – 5:00 ...
(Date:5/14/2020)... LINDA, Calif. (PRWEB) , ... May 12, 2020 ... ... life science tools for translational research, is bringing together thousands of industry leaders, ... The scientific program highlights two plenary speakers, Carl June, MD, Director of the ...
Breaking Biology Technology: